Library
2-Me-DMT
Also known as 2,N,N-TMT, this drug was first synthesised by Alexander Shulgin. Described as a very mild psychedelic of similar subjective effects to other tryptamines. Reported as having an unusual and unpredictable dose curve, it is recommended to start low with this drug.
Also known as: 2,N,N-TMT, 2-méthyl-DMT
Classification
- Chemical: Tryptamine
- Psychoactive: Psychedelic
- Tag: Research-Chemical
- Tag: Tentative
Effects
- Mentalphysical Stimulation
- Decreased Appetite
- Pupil Dilation
- Restlessness
- Sweatingchills
- Muscle Tension
- Euphoria
- Empathy
- Insight
- Change In Perception
- Ego Softening
- Confusion
- Brightened Color
- Closedopen Eye Visuals
- Enhanced Tactile Sensation
- Pitch Distortion
- Closed Eye Visuals
- Open Eye Visuals
Routes of Administration
Oral
Dosage
- Common: 50-75 mg
- Light: 30-50 mg
- Strong: 75-100 mg
- Heavy: 100+ mg
- Threshold: 15 mg
Duration
- Onset: 1-1.5 h
- Peak: 1-3 h
- Offset: 3-6 h
- After Effects: 0.5-5 h
- Total Duration: 4-6 h
Insufflated
Dosage
- Heavy: 50+ mg
- Light: 5-15 mg
- Common: 15-30 mg
- Strong: 30-50 mg
- Threshold: 5 mg
Duration
- Onset: 0.17-0.5 h
- Peak: 1-3 h
- Offset: 3-6 h
- After Effects: 0.5-4 h
- Total Duration: 3-6 h
Vaporized
Dosage
- Heavy: 20+ mg
- Light: 2-5 mg
- Common: 5-10 mg
- Strong: 10-20 mg
- Threshold: 2 mg
Duration
- Onset: 0-0.03 h
- Peak: 0.08-0.25 h
- Offset: 0.17-0.33 h
- After Effects: 0.25-2 h
- Total Duration: 0.25-1 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.